Annual CFI
-$656.15 K
+$13.96 M+95.51%
31 December 2023
Summary:
Sunshine Biopharma annual cash flow from investing activities is currently -$656.15 thousand, with the most recent change of +$13.96 million (+95.51%) on 31 December 2023. During the last 3 years, it has fallen by -$654.96 thousand (-54992.36%).SBFMW Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$578.37 K
-$36.16 K-6.67%
30 September 2024
Summary:
Sunshine Biopharma quarterly cash flow from investing activities is currently -$578.37 thousand, with the most recent change of -$36.16 thousand (-6.67%) on 30 September 2024. Over the past year, it has dropped by -$597.23 thousand (-3166.80%). SBFMW quarterly CFI is now -1102.33% below its all-time high of $57.70 thousand, reached on 30 June 2018.SBFMW Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$2.06 M
-$597.23 K-40.87%
30 September 2024
Summary:
Sunshine Biopharma TTM cash flow from investing activities is currently -$2.06 million, with the most recent change of -$597.23 thousand (-40.87%) on 30 September 2024. Over the past year, it has dropped by -$1.67 million (-432.03%). SBFMW TTM CFI is now -3208.55% below its all-time high of $66.22 thousand, reached on 31 March 2019.SBFMW TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.5% | -3166.8% | -432.0% |
| 3 y3 years | -10000.0% | -100.0% | -10000.0% |
| 5 y5 years | -4617.8% | -10000.0% | -10000.0% |
SBFMW Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | +95.5% | -3166.8% | +13.5% | at low | ||
| 5 y | 5 years | +95.5% | -3166.8% | +13.5% | at low | ||
| alltime | all time | <-9999.0% | +95.5% | -1102.3% | +13.5% | -3208.6% | at low |
Sunshine Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$578.37 K(+6.7%) | -$2.06 M(+40.9%) |
| June 2024 | - | -$542.21 K(-18.9%) | -$1.46 M(+24.0%) |
| Mar 2024 | - | -$668.74 K(+148.4%) | -$1.18 M(+79.6%) |
| Dec 2023 | -$656.15 K(-95.5%) | -$269.23 K(-1527.6%) | -$656.15 K(+69.6%) |
| Sept 2023 | - | $18.86 K(-107.3%) | -$386.92 K(-4.6%) |
| June 2023 | - | -$259.48 K(+77.4%) | -$405.78 K(+177.4%) |
| Mar 2023 | - | -$146.30 K(<-9900.0%) | -$146.30 K(<-9900.0%) |
| Dec 2022 | -$14.62 M(<-9900.0%) | - | - |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2021 | - | $0.00(0.0%) | -$391.00(-67.2%) |
| June 2021 | - | $0.00(0.0%) | -$1191.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) | -$1191.00(0.0%) |
| Dec 2020 | -$1191.00(-92.2%) | -$391.00(-51.1%) | -$1191.00(-28.3%) |
| Sept 2020 | - | -$800.00(<-9900.0%) | -$1660.00(-27.8%) |
| June 2020 | - | $0.00(0.0%) | -$2300.00(-84.9%) |
| Mar 2020 | - | $0.00(-100.0%) | -$15.28 K(0.0%) |
| Dec 2019 | -$15.28 K(+9.8%) | -$860.00(-40.3%) | -$15.28 K(+159.1%) |
| Sept 2019 | - | -$1440.00(-88.9%) | -$5896.00(+32.3%) |
| June 2019 | - | -$12.98 K(<-9900.0%) | -$4456.00(-106.7%) |
| Mar 2019 | - | $0.00(-100.0%) | $66.22 K(-576.1%) |
| Dec 2018 | -$13.91 K(-83.4%) | $8520.00(>+9900.0%) | -$13.91 K(-86.9%) |
| Sept 2018 | - | $0.00(-100.0%) | -$106.44 K(+26.5%) |
| June 2018 | - | $57.70 K(-172.0%) | -$84.14 K(-48.7%) |
| Mar 2018 | - | -$80.13 K(-4.6%) | -$164.14 K(+95.4%) |
| Dec 2017 | -$84.01 K(+2342.8%) | -$84.01 K(-476.8%) | -$84.01 K(+7565.0%) |
| Sept 2017 | - | $22.30 K(-200.0%) | -$1096.00(-95.3%) |
| June 2017 | - | -$22.30 K(<-9900.0%) | -$23.39 K(+580.2%) |
| Mar 2017 | - | $0.00(-100.0%) | -$3439.00(0.0%) |
| Dec 2016 | -$3439.00(-99.4%) | -$1096.00(<-9900.0%) | -$3439.00(-99.5%) |
| Sept 2016 | - | $0.00(-100.0%) | -$625.95 K(0.0%) |
| June 2016 | - | -$2343.00(<-9900.0%) | -$625.95 K(+0.4%) |
| Mar 2016 | - | $0.00(-100.0%) | -$623.60 K(0.0%) |
| Dec 2015 | -$623.60 K | -$623.60 K(<-9900.0%) | -$623.60 K(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2008 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00 | $0.00 |
| July 2007 | $0.00 | - | - |
FAQ
- What is Sunshine Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Sunshine Biopharma?
- What is Sunshine Biopharma annual CFI year-on-year change?
- What is Sunshine Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly CFI year-on-year change?
- What is Sunshine Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sunshine Biopharma?
- What is Sunshine Biopharma TTM CFI year-on-year change?
What is Sunshine Biopharma annual cash flow from investing activities?
The current annual CFI of SBFMW is -$656.15 K
What is the all time high annual CFI for Sunshine Biopharma?
Sunshine Biopharma all-time high annual cash flow from investing activities is $0.00
What is Sunshine Biopharma annual CFI year-on-year change?
Over the past year, SBFMW annual cash flow from investing activities has changed by +$13.96 M (+95.51%)
What is Sunshine Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of SBFMW is -$578.37 K
What is the all time high quarterly CFI for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly cash flow from investing activities is $57.70 K
What is Sunshine Biopharma quarterly CFI year-on-year change?
Over the past year, SBFMW quarterly cash flow from investing activities has changed by -$597.23 K (-3166.80%)
What is Sunshine Biopharma TTM cash flow from investing activities?
The current TTM CFI of SBFMW is -$2.06 M
What is the all time high TTM CFI for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM cash flow from investing activities is $66.22 K
What is Sunshine Biopharma TTM CFI year-on-year change?
Over the past year, SBFMW TTM cash flow from investing activities has changed by -$1.67 M (-432.03%)